Pennsylvania recognizes 24 qualifying medical conditions for its medical marijuana program, covering everything from cancer and PTSD to anxiety disorders and opioid use disorder. If you have a diagnosed condition on that list, you may be eligible for a medical marijuana card through a physician certification process.
Knowing whether your condition qualifies is the first step, but it is not the only step. Pennsylvania requires that a state-registered physician review your medical history and certify your diagnosis before you can access the program. This guide walks through every qualifying condition, explains what the certification process requires, and shows you how to move forward.
Pennsylvania’s Medical Marijuana Act, Act 16 of 2016, created the legal framework for the state’s medical cannabis program. The Pennsylvania Department of Health administers the program, and the qualifying medical conditions are defined by state statute, not by individual physician discretion.
Having a qualifying condition is necessary, but it doesn’t automatically entitle you to a card:
The program has expanded its qualifying conditions over time:
That growth reflects how Pennsylvania has continued to update its approach as evidence and patient need have evolved.
Pennsylvania’s qualifying medical conditions span a wide range of serious diagnoses. The Pennsylvania Department of Health publishes the authoritative list, and conditions may be added over time. The 24 conditions below, now including chronic hepatitis C, reflect the program’s list as of the most recent available update.
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic lateral sclerosis, commonly known as ALS, is a progressive neurodegenerative disease that damages the nerve cells controlling voluntary muscle movement. Cannabis may help manage pain, muscle spasticity, and difficulty sleeping in patients living with ALS.
Epilepsy
A 2025 review of cannabinoid mechanisms in epilepsy confirms CBD has significantly reduced seizure frequency in multiple large-scale, randomized, placebo-controlled trials, particularly for treatment-resistant epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.
Intractable Seizures
Intractable seizures are seizures that do not respond to standard antiepileptic medications, as explained in this overview of intractable epilepsy. Pennsylvania lists this separately from epilepsy to cover patients who experience refractory seizures regardless of underlying cause.
Multiple Sclerosis
Multiple sclerosis is an autoimmune condition in which the immune system attacks the protective covering of nerve fibers, disrupting communication between the brain and body. Cannabis may help manage the muscle spasticity and chronic pain that are common in MS, and it is one of the more widely studied qualifying medical conditions in this category.
Huntington’s Disease
Huntington’s disease is an inherited neurodegenerative disease that causes progressive breakdown of nerve cells in the brain. Patients may experience movement disorders, cognitive decline, and psychiatric symptoms, and cannabis may help manage some of those effects.
Parkinson’s Disease
Parkinson’s disease is a progressive nervous system disorder affecting movement. Cannabis may help address motor symptoms, sleep disturbances, and anxiety that frequently accompany a Parkinson’s diagnosis.
Neurodegenerative Diseases
Pennsylvania’s program includes neurodegenerative diseases as a broader category, covering conditions beyond those named individually. This catch-all provision allows certified physicians to determine whether a patient’s neurodegenerative condition falls within the program’s qualifying scope.
Tourette Syndrome
Tourette syndrome is a neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics. Cannabis may help reduce tic frequency and severity in some patients, though physician certification depends on documented diagnosis.
Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity
This qualifying condition covers patients who have sustained spinal cord damage resulting in spasticity that does not respond to conventional treatment. The “objective neurological indication” requirement means that a physician must document clinical evidence of the spasticity, not simply a patient’s self-report.
Dyskinetic and Spastic Movement Disorders
Dyskinetic and spastic movement disorders include conditions that cause involuntary, uncontrolled, or abnormally stiff movements. Cannabis may help manage the muscle rigidity and involuntary motion associated with these disorders.
Neuropathies
Neuropathies refer to conditions that result from damage to the peripheral nerves, often producing weakness, numbness, or pain. Chronic pain of neuropathic origin is one of the more common presentations among patients seeking physician certification under Pennsylvania’s program.
Post-Traumatic Stress Disorder (PTSD)
Post-traumatic stress disorder is a psychiatric condition that develops in some people following exposure to a traumatic event. Cannabis may help manage anxiety, hyperarousal, and sleep disruption in PTSD patients, and it is among the more commonly certified serious medical conditions in Pennsylvania’s program.
Anxiety Disorders
Anxiety disorders were added to Pennsylvania’s qualifying medical conditions list in 2019. A documented diagnosis from a licensed physician or mental health professional is required. See the dedicated section below for full detail on what qualifies and what documentation you will need.
Autism
Autism, or autism spectrum disorder, is a developmental condition that affects communication, behavior, and sensory processing. Cannabis may help manage behavioral symptoms and anxiety in some patients with autism, and Pennsylvania’s program recognizes it as a qualifying condition.
Severe Chronic or Intractable Pain
Pennsylvania qualifies two presentations of severe pain: chronic pain of neuropathic origin, and severe chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or inadequate. This is one of the most commonly cited qualifying conditions in the program and covers patients for whom standard pain management has not provided sufficient relief.
Inflammatory Bowel Disease
Inflammatory bowel disease covers conditions that cause chronic inflammation of the gastrointestinal tract, including Crohn’s disease and ulcerative colitis. Cannabis may help manage pain, nausea, and inflammation associated with these conditions.
Crohn’s Disease
Crohn’s disease is listed separately as well as within inflammatory bowel disease, reflecting the frequency with which it appears as a qualifying diagnosis. It causes inflammation that can affect any part of the digestive tract and often produces severe abdominal pain, diarrhea, and fatigue.
Glaucoma
Glaucoma is a group of eye conditions that damage the optic nerve, often due to elevated intraocular pressure. Cannabis has been studied for its potential to reduce intraocular pressure, making it a recognized qualifying condition in Pennsylvania’s program.
Sickle Cell Anemia
Sickle cell anemia is an inherited blood disorder that causes red blood cells to take on an abnormal shape, leading to episodes of severe pain, anemia, and organ damage. Cannabis may help manage the pain crises associated with this condition.
Chronic Hepatitis C
Chronic hepatitis C is a liver infection that can cause long-term complications including joint pain, fatigue, and nausea, both from the disease itself and from certain antiviral treatments. Cannabis may help manage treatment-related side effects and chronic symptoms in patients with an active or prior hepatitis C diagnosis.
HIV/AIDS
HIV/AIDS qualifies because of the chronic pain, nausea, and wasting that can accompany both the disease and its treatment. Cannabis may help manage appetite loss and treatment-related side effects in patients living with HIV/AIDS.
Opioid Use Disorder
Opioid use disorder qualifies under a specific harm-reduction rationale. See the dedicated section below for full detail.
Cancer
Cancer qualifies broadly, covering patients dealing with pain, nausea, and appetite loss related to the disease itself or to cancer treatment such as chemotherapy. Cannabis may help manage treatment side effects and improve quality of life during care.
Terminal Illness
Terminal illness qualifies patients who have received a diagnosis indicating that their condition is expected to result in death, according to clinical guidance on terminal illness. This category recognizes the palliative role cannabis can play in end-of-life care, including pain management and anxiety relief.
Two qualifying conditions catch many patients off guard: anxiety disorders and opioid use disorder. Neither is a fringe addition to Pennsylvania’s list, but both are conditions where patients frequently do not realize they may qualify, and where understanding the documentation requirements matters more than with most other diagnoses.
Anxiety disorders became qualifying medical conditions in Pennsylvania in 2019, making the state one of the earlier adopters to explicitly include them. Not every experience of anxiety qualifies. You need a documented diagnosis from a licensed physician or mental health professional, and the certifying cannabis physician will need to see that documentation before issuing certification.
The most commonly qualifying presentations are generalized anxiety disorder, social anxiety disorder, and panic disorder. Situational anxiety tied to a specific event or circumstance, without a formal diagnosis, is unlikely to meet the certification threshold. If you have been treated for anxiety by a therapist, psychiatrist, or primary care physician, ask that provider for your diagnostic records before your certification appointment.
Pennsylvania added opioid use disorder as a qualifying condition with an explicit harm-reduction rationale, directly tied to the state’s response to the opioid crisis. The program recognizes cannabis as a potential substitute for opioid therapy in patients for whom opioid therapy is otherwise indicated, and the certifying physician must determine that cannabis is clinically appropriate as an alternative. This is not a self-directed substitution; it requires physician oversight and documented diagnosis.
Framing matters here. A 2019 study published in Harm Reduction Journal found that among authorized medical cannabis patients who substituted cannabis for a prescription drug, opioids accounted for over a third of that substitution, with nearly 60% of those patients reporting they stopped using opioids entirely. This reflects the evidence basis Pennsylvania drew on when adding this condition.
Getting certified isn’t automatic, and this is where a lot of patients hit an unexpected snag. Only physicians registered with the Pennsylvania Medical Marijuana Program can certify patients. It’s not a general medical license requirement, it’s a specific state registration, and plenty of licensed PA physicians haven’t completed it.
Once you’re with a registered physician, they’ll review your medical history and confirm your qualifying condition before submitting certification electronically to the state, that submission, not a paper certificate, is what actually moves your application forward. Bring documentation: medical records, prior prescriptions, imaging, or a provider letter.
Documentation matters most where a diagnosis is harder to verify on sight: anxiety, PTSD, opioid use disorder, and severe chronic pain all benefit from a clear paper trail. Cancer or ALS, by contrast, usually speak for themselves through existing records. When in doubt, call ahead and ask what to bring.
One thing worth knowing upfront: having a qualifying condition makes you eligible, not automatically approved. A physician who decides cannabis isn’t clinically appropriate for you isn’t required to certify you, even if your diagnosis is on the list.
A primary care physician can certify you for Pennsylvania’s medical marijuana program, but only if they are registered with the Pennsylvania Department of Health’s Medical Marijuana Program. Many primary care doctors have not completed that registration, either because they are unfamiliar with the process or because their practice has chosen not to participate.
If your own doctor is not registered, you are not out of options. Telehealth platforms that specialize in telemedicine for medical cannabis connect patients with physicians who are registered with the Pennsylvania program, allowing you to complete your certification appointment remotely and without switching away from your regular care provider for other needs.
Once you have confirmed your qualifying condition, the application process follows a clear sequence. Understanding how long it takes to get a medical card before you start helps you plan around processing timelines managed by the Commonwealth, not by your certifying physician.
Pennsylvania offers a state fee waiver for patients who receive Medicaid, SNAP, WIC, PACE/PACENET, or CHIP benefits through the Medical Marijuana Program for Patient Assistance (MMAP). If you qualify for any of those programs, you may be able to receive your card without the $50 fee.
Understanding the benefits of a medical marijuana card beyond dispensary access can also help you decide whether pursuing a card makes sense for your situation. Cardholders in Pennsylvania may also want to know whether a medical marijuana card shows up on a background check before applying, and whether medical marijuana is covered by insurance to set realistic financial expectations.
If you travel or move, you may also want to check states that honor out-of-state medical marijuana cards and review medical marijuana card state-by-state laws so you understand your rights and restrictions when you are outside Pennsylvania.
Ready to find out if you qualify? Connect with a Pennsylvania-registered certifying physician through Veriheal’s telehealth platform and complete your certification appointment from home. For guidance on how to get your medical marijuana card online, Veriheal’s step-by-step guide walks you through the full process.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Note: Veriheal does not support illegally consuming therapeutic substances such as cannabis but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.
Pennsylvania’s medical marijuana program recognizes 24 qualifying medical conditions, spanning neurological disorders, psychiatric conditions, chronic and inflammatory diseases, and terminal illnesses. The list includes cancer, PTSD, epilepsy, multiple sclerosis, Crohn’s disease, anxiety disorders, opioid use disorder, sickle cell anemia, and severe chronic pain, among others. A registered certifying physician must confirm your diagnosis before you can receive a card.
Getting a Pennsylvania medical marijuana card involves registering in the state patient registry, completing a certification appointment with a PA DOH-registered physician, and paying a $50 state fee after your physician submits your electronic certification.
Yes, since 2019. As with any qualifying condition, self-reported symptoms alone are not enough; your certifying physician needs to see supporting documentation of the diagnosis before issuing a certification.
The Pennsylvania state fee for a medical marijuana card is $50, with a fee waiver available for medical marijuana patients who receive Medicaid, SNAP, WIC, PACE/PACENET, or CHIP benefits. Physician certification fees vary by provider.
Yes, but only if they’ve completed the state’s registration process, and many haven’t. Patients whose own doctor isn’t registered typically use a cannabis-specific telehealth service instead.
Oklahoma’s medical-only dispensary market gives licensed patients access to a wide range of cannabis products, but every purchase must follow OMMA rules. This guide explains how to find licensed dispensaries, what identification to bring, purchase and possession limits, product testing, pricing, and what to expect during a visit.
Oklahoma’s advertised $25 medical marijuana card renewal covers the physician evaluation, but patients must also pay a separate OMMA license fee. This guide explains the full renewal cost, reduced-fee eligibility, required documents, online renewal steps, processing times, and the new physician recommendation requirement.
An Oklahoma medical marijuana card provides legal protection under state law, but it can still affect employment, commercial driving, firearms, privacy, and federally regulated situations. This guide explains the main consequences to consider before applying, including workplace drug testing, CDL rules, insurance, housing, and registry privacy.
Getting a medical marijuana card in Oklahoma can be completed online, with no specific qualifying condition required for adult applicants. This guide covers eligibility, telehealth evaluations, required documents, OMMA application steps, fees, processing times, and what patients can do once approved.
A same-day telehealth appointment in Oklahoma can get you a physician recommendation quickly, but OMMA still needs to process your medical marijuana license application. This guide explains the timeline, required documents, costs, and when you can legally visit a dispensary while waiting for the physical card.
Sign up for our newsletter
Learn the process in your state
All Rights Reserved Veriheal Inc. ©
Terms Privacy Policy Advertising Agreement Content Disclamer
Get your medical marijuana card today
Sign up in under 5 minutes
Start By Selecting Your State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Puerto Rico
